Background: Despite the availability of various dietary assessment tools, there is a need for a tool aligned with the needs of lifestyle medicine (LM) physicians. Such a tool would be brief, aimed at use in a clinical setting, and focused on a "food as medicine" approach consistent with recommendations for a diet based predominately on whole plant foods. The objective of this study is to describe the development and initial pilot testing of a brief, dietary screener to assess the proportion of whole, unrefined plant foods and water relative to total food and beverage intake.

Methods: A multidisciplinary study team led the screener development, providing input on the design and food/beverage items included, and existing published dietary assessment tools were reviewed for relevance. Feedback was solicited from LM practitioners in the form of a cross-sectional survey that captured information on medical practice, barriers, and needs in assessing patients' diets, in addition to an opportunity to complete the screener and provide feedback on its utility. The study team assessed feedback and revised the screener accordingly, which included seeking and incorporating feedback on additional food items to be included from subject matter experts in specific cultural and ethnic groups in the United States. The final screener was submitted for professional design, and scoring was developed.

Results: Of 539 total participants, the majority reported assessing diet either informally (62%) or formally (26%) during patient encounters, and 73% reported discussing diet with all or most of their patients. Participants also reported facing barriers (80%) to assessing diet. Eighty-eight percent believed the screener was quick enough to use in a clinical setting, and 68% reported they would use it.

Conclusion: The ACLM Diet Screener was developed through iterative review and pilot testing. The screener is a brief, 27-item diet assessment tool that can be successfully used in clinical settings to track patient dietary intakes, guide clinical conversations, and support nutrition prescriptions. Pilot testing of the screener found strong alignment with clinician needs for assessing a patient's intake of whole plant food and water relative to the overall diet. Future research will involve pilot testing the screener in clinical interventions and conducting a validation study to establish construct validity.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11085256PMC
http://dx.doi.org/10.3389/fnut.2024.1356676DOI Listing

Publication Analysis

Top Keywords

pilot testing
16
screener
12
diet screener
12
testing screener
12
diet
9
plant food
8
food water
8
lifestyle medicine
8
aclm diet
8
dietary assessment
8

Similar Publications

Bullying Behaviors in Clinical Settings: Potentially Harmful Distractions.

Nurs Educ Perspect

January 2025

About the Authors Dawna Rutherford, PhD, RN, adjunct clinical instructor, Salem State University, Salem, Massachusetts, is with Staff Nurse/Traveler RN Network, Nome, Alaska. Gordon Lee Gillespie, PhD, DNP, RN, was professor, College of Nursing, University of Cincinnati, Cincinnati, Ohio, when this study was conducted. He is currently chief program officer, National League for Nursing. Scott Bresler, PhD, was clinical director, Division of Forensic Psychiatry, University of Cincinnati College of Medicine, when this study was conducted. Kimberly Johnson, PhD, RN, CEN, and Carolyn R. Smith, PhD, RN, CNE, are associate professors, College of Nursing, University of Cincinnati. This study was funded by an award to Dr. Rutherford from the National Institute for Occupational Safety and Health through the Pilot Research Project Training Program of the University of Cincinnati Education and Research Center Grant #T42OH008432. For more information, contact Dr. Gillespie at

Nursing students exposed to bullying behaviors are at risk for making medication errors. For a quasi-experimental study, 15 prelicensure nursing students at a Midwestern university were exposed to simulated bullying behaviors or common distractions while administering medications in a laboratory setting. Data were analyzed using Kruskal-Wallis tests.

View Article and Find Full Text PDF

Spinal muscular atrophy (SMA) is a degenerative neuromuscular condition resulting from a homozygous deletion of the survival motor neuron 1 () gene in 95% of patients. A timely diagnosis via newborn screening (NBS) and initiating treatment before the onset of symptoms are critical for improving health outcomes in affected individuals. We carried out a screening test by quantitative PCR (qPCR) to amplify the exon seven of using dried blood spot (DBS) samples.

View Article and Find Full Text PDF

Visual Noise Mask for Human Point-Light Displays: A Coding-Free Approach.

NeuroSci

January 2025

Psychological Neuroscience Laboratory, Psychology Research Center, School of Psychology, University of Minho, Rua da Universidade, 4710-057 Braga, Portugal.

Human point-light displays consist of luminous dots representing human articulations, thus depicting actions without pictorial information. These stimuli are widely used in action recognition experiments. Because humans excel in decoding human motion, point-light displays (PLDs) are often masked with additional moving dots (noise masks), thereby challenging stimulus recognition.

View Article and Find Full Text PDF

Introduction: Subsea applications recently received increasing attention due to the global expansion of offshore energy, seabed infrastructure, and maritime activities; complex inspection, maintenance, and repair tasks in this domain are regularly solved with pilot-controlled, tethered remote-operated vehicles to reduce the use of human divers. However, collecting and precisely labeling submerged data is challenging due to uncontrollable and harsh environmental factors. As an alternative, synthetic environments offer cost-effective, controlled alternatives to real-world operations, with access to detailed ground-truth data.

View Article and Find Full Text PDF

Introduction: Monogenic diseases can be diagnosed before birth. Systemic fetal administration of nanoparticles (NPs) grants therapeutic access to developing stem cell populations impacted by these classes of disease. Delivery of editing reagents in these NPs administered before birth has yielded encouraging results in preclinical mouse models of monogenic diseases.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!